文献
J-GLOBAL ID:201202236506277745
整理番号:12A1699050
進行性腎細胞癌のファーストライン治療としての間欠的と連続的投与計画を対比するスニチニブの無作為化第II相試験
Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma
著者 (17件):
MOTZER Robert J.
(Memorial Sloan-Kettering Cancer Center)
,
HUTSON Thomas E.
(Baylor Sammons Cancer Center-Texas Oncology, TX)
,
OLSEN Mark R.
(Cancer Care Associates, OK)
,
HUDES Gary R.
(Fox Chase Cancer Center, PA)
,
BURKE John M.
(Rocky Mountain Cancer Centers, CO)
,
EDENFIELD William J.
(Cancer Centers of the Carolinas, SC)
,
WILDING George
(Univ. of Wisconsin Carbone Cancer Center, WI)
,
AGARWAL Neeraj
(Univ. of Utah, UT)
,
THOMPSON John A.
(Seattle Cancer Care Alliance, WA)
,
CELLA David
(Northwestern Univ. Feinberg School of Medicine, IL)
,
BELLO Akintunde
(Pfizer Oncology, NY)
,
KORYTOWSKY Beata
(Pfizer Oncology, NY)
,
YUAN Jinyu
(Pfizer Oncology, NY)
,
VALOTA Olga
(Pfizer Oncology, Milan, ITA)
,
MARTELL Bridget
(Pfizer Oncology, NY)
,
HARIHARAN Subramanian
(Pfizer Oncology, NY)
,
FIGLIN Robert A.
(Cedars-Sinai Medical Center, CA)
資料名:
Journal of Clinical Oncology
(Journal of Clinical Oncology)
巻:
30
号:
12
ページ:
1371-1377
発行年:
2012年04月20日
JST資料番号:
E0307D
ISSN:
0732-183X
資料種別:
逐次刊行物 (A)
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)